266 related articles for article (PubMed ID: 9179217)
1. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy.
Carril JM; Gómez-Barquín R; Quirce R; Tabuenca O; Uriarte I; Montero A
Anticancer Res; 1997; 17(3B):1677-81. PubMed ID: 9179217
[TBL] [Abstract][Full Text] [Related]
2. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
4. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
[TBL] [Abstract][Full Text] [Related]
6. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
8. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
[TBL] [Abstract][Full Text] [Related]
9. A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography.
Scopinaro F; Schillaci O; Ussof W; Nordling K; Capoferro R; De Vincentis G; Danieli R; Ierardi M; Picardi V; Tavolaro R; Colella AC
Anticancer Res; 1997; 17(3B):1631-4. PubMed ID: 9179208
[TBL] [Abstract][Full Text] [Related]
10. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
11. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
Fondrinier E; Muratet JP; Anglade E; Fauvet R; Berger V; Lorimier G; Jallet P
Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L
Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209
[TBL] [Abstract][Full Text] [Related]
14. Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions.
Sanidas EE; Koukouraki S; Velidaki A; Manios A; Stathopoulos E; De Bree E; Kafousi M; Kodogiannis E; Karkavitsas N; Tsiftsis DD
Nucl Med Commun; 2003 Mar; 24(3):291-6. PubMed ID: 12612470
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
Gutfilen B; Fonseca LM
J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
[TBL] [Abstract][Full Text] [Related]
16. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
17. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
Yildiz A; Colak T; Güngör F; Ozuğur S; Boz A; Tunçdemir F; Akaydin M
Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
20. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
